PALISADE BIO INCPALI

Bearish

ASignal's systematic analysis rates PALI as Bearish.

Reflects the latest available analysis · analyzed Oct 8, 2026

The case on PALI

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong financial health score (0.9)
  • High cash position with no debt (debt-to-equity = 0)
  • Exceptional gross margin (100.00%)
  • High current and quick ratios indicating strong liquidity
VS
Bear case
  • Negative operating margin (-2339.60%)
  • Negative return on equity (-51.37%) and return on assets (-32.98%)
  • Negative free cash flow ($-8.65M)
  • Overvalued metrics: extremely high P/S ratio (515.84x) and EV/Revenue (265.50x)
  • Negative price momentum and trading below key moving averages (SMA20, SMA50)
  • MACD below signal line with slightly negative histogram
Subscriber-only

See the full verdict on PALI

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes PALI

Most investors never get a second opinion, let alone several. ASignal runs PALI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

PALISADE BIO INC (PALI) Stock Analysis - ASignal rates it Bearish